{"nctId":"NCT00501969","briefTitle":"An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease","startDateStruct":{"date":"2004-08"},"conditions":["Advanced Stage Parkinson's Disease"],"count":395,"armGroups":[{"label":"Rotigotine","type":"EXPERIMENTAL","interventionNames":["Drug: Rotigotine"]}],"interventions":[{"name":"Rotigotine","otherNames":["NeuproÂ®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who have completed four months of maintenance treatment in the SP515 (NCT00244387) double-blind trial\n\nExclusion Criteria:\n\n* Subjects who had an ongoing serious adverse event from SP515 (NCT00244387) double-blind trial that was assessed as related to study medication","healthyVolunteers":false,"sex":"ALL","minimumAge":"31 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With at Least One Adverse Event During This Open-label Extension Study","description":"Adverse events are any untoward medical occurrences in a subject administered study treatment, whether or not these events are related to treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"357","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Who Withdrew From the Trial Due to an Adverse Event","description":"Adverse events are any untoward medical occurrences in a subject administered study treatment, whether or not these events are related to treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Epworth Sleepiness Scale Score During the Open-label Extension","description":"The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire with 8 questions. The total ESS score is the sum of 8 item-scores and can range between 0 and 24. The higher the score, the higher the person's level of daytime sleepiness.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":"4.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":"5.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"5.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.3","spread":"5.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":148,"n":395},"commonTop":["Somnolence","Fall","Dyskinesia","Nausea","Back pain"]}}}